All In MedTech

FDA Clearance Tracker · P150048-S073

INSPIRIS RESILIA Aortic Valve, Model 11500A

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 27, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 27, 2023

Approved

Time to decision

24 days

Received Jul 3, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P150048-S073
Device name
INSPIRIS RESILIA Aortic Valve, Model 11500A
Applicant location
Irvine, CA
Received
Jul 3, 2023
Decided
Jul 27, 2023
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P150048

Device type

Device class
Class III

Every decision under product code LWR

FDA's approval statement

As written in FDA's record.

Approval for the revised protocol for the post-approval study (PAS), Model 11500A Prospective PAS.

Source documents

Other decisions for Edwards Lifesciences, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.